LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in LENZ Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 161
- −5 vs. Q3 2025
- Shares held
- 35.1M
- +5.93M (+20.4%) vs. Q3 2025
- Total value
- $561.6M
- −$794.0M (−58.6%) vs. Q3 2025
- New holders
- 50
- 53 more added
- Sold out
- 55
- 33 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $725.1M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.8M |
| Q2 2024 | 65 | $327.0M |
| Q1 2024 | 55 | $362.0M |
| Q4 2023 | 63 | $81.5M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $431.7M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $981.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,147−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −608−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −577−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −244−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Washington Trust Advisors, Inc. | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |